Objective: To determine the efficacy of anakinra (recombinant interleukin-1 receptor antagonist) in improving 28-day survival in sepsis patients with features of macrophage activation syndrome. Despite equivocal results in sepsis trials, anakinra is effective in treating macrophage activation syndrome, a similar entity with fever, disseminated intravascular coagulation, hepatobiliary dysfunction, cytopenias, and hyperferritinemia. Hence, sepsis patients with macrophage activation syndrome features may benefit from interleukin-1 receptor blockade. Design: Reanalysis of deidentified data from the phase III randomized interleukin-1 receptor antagonist trial in severe sepsis. Setting: Multicenter study recruiting through 91 centers from 11 countries in Europe and North America. Patients: Sepsis patients with multiorgan dysfunction syndrome and/or shock (original study) were regrouped based on the presence or the absence of concurrent hepatobiliary dysfunction and disseminated intravascular coagulation as features of macrophage activation syndrome. The non-hepatobiliary dysfunction/disseminated intravascular coagulation group included patients with only hepatobiliary dysfunction, only disseminated intravascular coagulation, or neither. Intervention: Treatment with anakinra or placebo. Measurements and Main Results: Main outcome was 28-day mortality. Descriptive and comparative statistics were performed. Data were available for 763 adults from the original study cohort, randomized to receive either anakinra or placebo. Concurrent hepatobiliary dysfunction/disseminated intravascular coagulation was noted in 43 patients (5.6% of total; 18-75 years old; 47% women). The 28-day survival was similar in both anakinra and placebo-treated non-hepatobiliary dysfunction/disseminated intravascular coagulation patients (71.4% vs 70.8%; p = 0.88). Treatment with anakinra was associated with significant improvement in the 28-day survival rate in hepatobiliary dysfunction/disseminated intravascular coagulation patients (65.4% anakinra vs 35.3% placebo), with hazard ratio for death 0.28 (0.11-0.71; p = 0.0071) for the treatment group in Cox regression. Conclusions: In this subgroup analysis, interleukin-1 receptor blockade was associated with significant improvement in survival of patients with sepsis and concurrent hepatobiliary dysfunction/disseminated intravascular coagulation. A prospective randomized trial using features of macrophage activation syndrome for mortality risk stratification should be undertaken to confirm the role of interleukin-1 blockage. Copyright (C) by 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
from #Medicine via ola Kala on Inoreader http://ift.tt/1N8IO5d
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
- ► Δεκεμβρίου (940)
-
▼
Οκτωβρίου
(414)
-
▼
Οκτ 28
(41)
- Paula J. Martin. Suzanne Noël: Cosmetic Surgery, ...
- Samuel J. M. M. Alberti (ed.), War, Art and Surger...
- Jens Gründler, Armut und Wahnsinn: 'Arme Irre' un...
- Clare Debenham, Birth Control and the Rights of Wo...
- Julia Skelly, Addiction and British Visual Culture...
- Clinical analysis of patients suffering from chron...
- Place and Response Learning in the Open-field Towe...
- Effects and Mechanisms by Which Hypercapnic Acidos...
- Numerical Modeling of Fluid-Structure Interaction ...
- Screening of presumptive urinary tract infections ...
- Laboratory testing requirements for diagnosis and ...
- Heparinate but not serum tubes are susceptible to ...
- Eryptosis is induced by hyperthermia in hereditary...
- Crystalluria
- In the News: A roundup of news and information fro...
- Prelim
- Mercy Virtual in the News Again
- Reversible Electrochemical Sensor for Detection of...
- Chemo-Enzymatic Synthesis of 13C Labeled Complex N...
- High-Speed, Integrated Ablation Cell and Dual Conc...
- Analysis of cervical resistance during continuous ...
- Functional demonstrations of starch binding domain...
- Thallium-201 is comparable to technetium-99m-sesta...
- Intravenous paracetamol for relief of pain during ...
- Photodynamic Therapy with Blended Conducting Polym...
- Spinal Cord Infarct During Concomitant Circulatory...
- Kidney and Liver Injuries After Major Burns in Rat...
- Incidence and Mortality of Acute Respiratory Distr...
- Trait Anxiety But Not State Anxiety During Critica...
- Endotoxemia Following Multiple Trauma: Risk Factor...
- Failure of Noninvasive Ventilation for De Novo Acu...
- Does Thrombolysis Have a Place in the Cardiopulmon...
- Excellence in Intensive Care Medicine.
- Interleukin-1 Receptor Blockade Is Associated With...
- Recruitment Maneuvers and Positive End-Expiratory ...
- Shared Decision Making in ICUs: An American Colleg...
- Long-Term Outcome Following Tracheostomy in Critic...
- The q-G method : A q-version of the Steepest Desce...
- Characterization of Traveling Wave Ion Mobility Se...
- Silver Coating for High-Mass-Accuracy Imaging Mass...
- Ultrasensitive Detection of Dual Cancer Biomarkers...
-
▼
Οκτ 28
(41)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.